| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_KLHL2_0002300 | Exon-Exon | chr4:166149959-166231902 | chr4:165228807-165310750 | 1085 nt | 0.4571 |
| hsa_KLHL2_0002700 | Exon-Exon | chr4:166159930-166184511 | chr4:165238778-165263359 | 285 nt | 0.4456 |
| hsa_KLHL2_0003100 | Exon-Exon | chr4:166184349-166218877 | chr4:165263197-165297725 | 390 nt | 0.4359 |
| hsa_KLHL2_0003200 | Exon-Exon | chr4:166184349-166220808 | chr4:165263197-165299656 | 540 nt | 0.4444 |
| hsa_KLHL2_0003800 | Exon-Exon | chr4:166215511-166220808 | chr4:165294359-165299656 | 377 nt | 0.4324 |
| hsa_KLHL2_0004400 | Exon-Exon | chr4:166220659-166231902 | chr4:165299507-165310750 | 466 nt | 0.4914 |
| hsa_KLHL2_0004800 | Exon-Exon | chr4:166226760-166231902 | chr4:165305608-165310750 | 316 nt | 0.5032 |
| hsa_KLHL2_0004900 | Exon-Exon | chr4:166226760-166232717 | chr4:165305608-165311565 | 418 nt | 0.4880 |
| hsa_KLHL2_0005300 | Exon-Exon | chr4:166231705-166231902 | chr4:165310553-165310750 | 198 nt | 0.4848 |
| hsa_KLHL2_0005600 | Exon-Exon | chr4:166232616-166234518 | chr4:165311464-165313366 | 231 nt | 0.4502 |
A study in humans identified the circKLHL2 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically characterized [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in mice and human patients demonstrated that the circKLHL2 may expedite sepsis-induced acute lung injury by adjusting the miR-29b-3p/ROCK axis [Xu et al. DOI:10.1080/01902148.2024.2429184].